Last update 01 Nov 2024
H1 receptor x δ opioid receptor x κ opioid receptor x σ1 receptor x D2 receptor x Muscle-type nAChRs x μ opioid receptor x 5-HT2 receptor
Last update 01 Nov 2024
Basic Info
Related Targets |
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
A Multicenter, Open Label, Escalating Dose Study to Assess the Tolerability and the Safety and to Explore the Efficacy and the Pharmacokinetics of ND0801 in Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)
100 Clinical Results associated with H1 receptor x δ opioid receptor x κ opioid receptor x σ1 receptor x D2 receptor x Muscle-type nAChRs x μ opioid receptor x 5-HT2 receptor
Login to view more data
100 Translational Medicine associated with H1 receptor x δ opioid receptor x κ opioid receptor x σ1 receptor x D2 receptor x Muscle-type nAChRs x μ opioid receptor x 5-HT2 receptor
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free